EU Mandates Monthly Safety Summaries For Approved COVID-19 Vaccines
Executive Summary
EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.
You may also be interested in...
Moderna Lauds Joint Work With Health Authorities On Spikevax Safety Monitoring
A senior executive at Moderna recounts how the company used a variety of data sources to identify potential safety signals for its Spikevax COVID-19 vaccine during a state of “hyper-pharmacovigilance.”
Norway COVID-19 Vaccine Deaths Draw Global Attention
Reports from Norway about deaths in very frail, elderly patients soon after receiving Pfizer/BioNTech’s COVID-19 jab have drawn regulatory scrutiny. While the European Medicines Agency has launched an investigation, Australia is examining the need for specific warnings about risks of vaccination in the very frail elderly or terminally ill patients.
EMA All Set To Oversee Use Of COVID-19 Treatments, Vaccines In Clinical Practice
The European Medicines Agency has finalized infrastructure to monitor the safety and effectiveness of COVID-19 medicines and vaccines when they are used in day-to-day clinical practice following marketing authorization.